Literature DB >> 31693967

Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China.

Xuli Zhang1, Peibing Zheng1, Jérôme J Devaux2, Yan Wang1, Chen Liu1, Jing Li3, Shougang Guo4, Yan Song5, Qian Wang5, Xungang Feng6, Yuzhong Wang7.   

Abstract

Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) seropositive for autoantibodies against nodal and paranodal proteins display distinct clinical presentations. We herein tested for autoantibodies against neurofascin (NF) 155, NF186, contactin-associated protein 1 and contactin-1 and investigated the autoantibody-related clinical features in 29 patients with CIDP from China. Six patients with anti-NF155 IgG4 antibodies displayed younger age of onset and poor response to intravenous immunoglobulin than seronegative patients. One patient had anti-NF186 IgG antibody and no patients had anti-contactin-associated protein 1 or anti-contactin-1 antibodies. Clinical features of CIDP patients with anti-NF155 antibodies in China were similar to those reported in other countries.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoantibody; Chronic inflammatory demyelinating polyneuropathy; Clinical features; Nodal protein

Mesh:

Substances:

Year:  2019        PMID: 31693967     DOI: 10.1016/j.jneuroim.2019.577074

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

Review 1.  Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review.

Authors:  Michele Goulart Dos Santos; Lucia Emanueli Schimith; Corinne André-Miral; Ana Luiza Muccillo-Baisch; Bruno Dutra Arbo; Mariana Appel Hort
Journal:  Neurotox Res       Date:  2022-01-11       Impact factor: 3.911

Review 2.  Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.

Authors:  Lisha Tang; Qianyi Huang; Zhen Qin; Xiangqi Tang
Journal:  J Neurol       Date:  2020-04-07       Impact factor: 4.849

Review 3.  Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations.

Authors:  Ze Wang; Xiajun Zhou; Nan Zhao; Chong Xie; Desheng Zhu; Yangtai Guan
Journal:  Neurol Sci       Date:  2021-03-29       Impact factor: 3.307

4.  Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.

Authors:  Giuseppe Liberatore; Alberto De Lorenzo; Claudia Giannotta; Fiore Manganelli; Massimiliano Filosto; Giuseppe Cosentino; Dario Cocito; Chiara Briani; Andrea Cortese; Raffaella Fazio; Giuseppe Lauria; Angelo Maurizio Clerici; Tiziana Rosso; Girolama Alessandra Marfia; Giovanni Antonini; Guido Cavaletti; Marinella Carpo; Pietro Emiliano Doneddu; Emanuele Spina; Stefano Cotti Piccinelli; Erdita Peci; Luis Querol; Eduardo Nobile-Orazio
Journal:  Neurol Sci       Date:  2022-01-20       Impact factor: 3.307

5.  A Systematic Review and Meta-Analysis of Autoantibodies for Diagnosis and Prognosis in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Authors:  Xiaoqian Guo; Lisha Tang; Qianyi Huang; Xiangqi Tang
Journal:  Front Neurosci       Date:  2021-05-24       Impact factor: 4.677

Review 6.  Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).

Authors:  Edyta Dziadkowiak; Marta Waliszewska-Prosół; Marta Nowakowska-Kotas; Sławomir Budrewicz; Zofia Koszewicz; Magdalena Koszewicz
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

7.  Optic Nerve Demyelination in IgG4 Anti-Neurofascin 155 Antibody-Positive Combined Central and Peripheral Demyelination Syndrome.

Authors:  Alice Verghese; Dhayalan Krishnan; Yuen Kang Chia; Luis Querol; Fu Liong Hiew
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-06

8.  Clinical and diagnostic features of anti-neurofascin-155 antibody-positive neuropathy in Han Chinese.

Authors:  Wenqing Wang; Chang Liu; Wei Li; Dong Zhang; Yi Shan; Jinfan Zheng; Jingli Shan; Yuying Zhao; Chuanzhu Yan; Qinzhou Wang
Journal:  Ann Clin Transl Neurol       Date:  2022-03-21       Impact factor: 5.430

9.  IgG4 Valency Modulates the Pathogenicity of Anti-Neurofascin-155 IgG4 in Autoimmune Nodopathy.

Authors:  Alexandre Jentzer; Arthur Attal; Clémence Roué; Julie Raymond; Cinta Lleixà; Isabel Illa; Luis Querol; Guillaume Taieb; Jérôme Devaux
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-08-10

Review 10.  Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.

Authors:  Jun-Ichi Kira
Journal:  Front Neurol       Date:  2021-06-10       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.